Predisposition Biomarkers Market Size

  • Report ID: 3090
  • Published Date: Dec 24, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.

The growth of the market can be attributed to the various advantages provided by biomarkers in reducing and monitoring the risks of several acute and chronic disease, along with aid in diagnosis and treatment. The use of biomarkers, significantly reduces the healthcare expenditure, as it monitors the health beforehand, which is estimated to boost its demand throughout the forecast period. Moreover, the rising prevalence of diseases, such as, cancer, and diabetes along with increasing government initiatives to reduce the cases of such diseases, is anticipated to promote the market growth. According to the data by the WHO, over 422 million people around the world suffer from diabetes, and it causes about 1.6 million deaths every year. Furthermore, introduction of novel and advanced technologies, such as, digital biomarkers, and escalating adoption of personalized medicines is projected to boost the market growth.



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Predisposition Biomarkers Market size is expected to register remarkable growth rate during the forecast period i.e., between 2025-2037.

Rising prevalence of the acute and chronic disease, and growing R&D investment for medical research will impel the market growth.

North America industry is poised to account for largest revenue share by 2037, owing to undergoing advanced research and development in the healthcare sector along with innovative clinical experiments, and development of new diagnostic tools.

The major players in the market are Danaher Corporation, Biomarker Technologies, Inc., Almac Group Limited, Myriad Genetics, Inc., F. Hoffmann-La Roche Ltd, Epigenomics AG, Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., QIAGEN GmbH and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos